NasdaqGM:ZLABBiotechs
What Is Drawing Fresh Attention To Zai Lab (ZLAB)?
Zai Lab (ZLAB) is back in focus after its second quarter 2026 earnings update, which showed revenue of US$106.31 million and a wider net loss, alongside fresh attention on newly approved products in China.
See our latest analysis for Zai Lab.
At a share price of US$23.57, Zai Lab has seen strong short term momentum, with a 7 day share price return of 29.65% and year to date share price return of 36.01%. The 1 year total shareholder return is still down 32%, which signals that recent...